For: | Huang ZM, Huang QW, Qin YQ, He YZ, Qin HJ, Zhou YN, Xu X, Huang MJ. YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines. World J Gastroenterol 2005; 11(6): 867-870 [PMID: 15682483 DOI: 10.3748/wjg.v11.i6.867] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/867.htm |
Number | Citing Articles |
1 |
Amitis Ramezani, Ali Akbar Velayati, Mohammad Reza Hasanjani Roshan, Latif Gachkar, Mohammad Banifazl, Hossein Keyvani, Arezoo Aghakhani. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. International Journal of Infectious Diseases 2008; 12(3): 252 doi: 10.1016/j.ijid.2007.08.003
|
2 |
Fuchu Qian, Jiqu Qin, Dongli Li, Hairong Zhang, Zhaowei Tong, Weihong Wang. Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China. The Brazilian Journal of Infectious Diseases 2016; 20(6): 645 doi: 10.1016/j.bjid.2016.07.014
|
3 |
Zhi-Jun Yang, Mei-Zeng Tu, Jian Liu, Xiao-Ling Wang, Hong-Zhi Jin. Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B. World Journal of Gastroenterology 2006; 12(44): 7192-7196 doi: 10.3748/wjg.v12.i44.7192
|
4 |
Akihito Tsubota. How do naturally occurring YMDD‐motif mutants influence the clinical course of lamivudine‐naïve patients with chronic hepatitis B virus infection?. Journal of Gastroenterology and Hepatology 2006; 21(12): 1769 doi: 10.1111/j.1440-1746.2006.04768.x
|
5 |
Nicola Coppola, Gilda Tonziello, Piero Colombatto, Mariantonietta Pisaturo, Vincenzo Messina, Francesco Moriconi, Loredana Alessio, Caterina Sagnelli, Daniela Cavallone, Maurizia Brunetto, Evangelista Sagnelli. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. Journal of Infection 2013; 67(4): 322 doi: 10.1016/j.jinf.2013.06.006
|
6 |
Ming‐Lun Yeh, Ching‐I. Huang, Ming‐Yen Hsieh, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Jee‐Fu Huang, Chia‐Yen Dai, Zu‐Yau Lin, Shinn‐Chern Chen, Ming‐Lung Yu, Wan‐Long Chuang. Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open‐label, multicenter study. The Kaohsiung Journal of Medical Sciences 2016; 32(11): 559 doi: 10.1016/j.kjms.2016.08.014
|
7 |
M. H. NGUYEN, R. T. GARCIA, H. N. TRINH, H. A. NGUYEN, K. K. NGUYEN, L. H. NGUYEN, B. LEVITT. Prevalence of hepatitis B virus DNA polymerase mutations in treatment‐naïve patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2009; 30(11-12): 1150 doi: 10.1111/j.1365-2036.2009.04151.x
|
8 |
Philip Vutien, Huy N. Trinh, Ruel T. Garcia, Huy A. Nguyen, Brian S. Levitt, Khanh Nguyen, Eduardo da Silveira, Tami Daugherty, Aijaz Ahmed, Gabriel Garcia, Glen A. Lutchman, Mindie H. Nguyen. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Clinical Gastroenterology and Hepatology 2014; 12(8): 1363 doi: 10.1016/j.cgh.2013.11.036
|
9 |
Bhupesh Singla, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. Journal of Medical Virology 2013; 85(7): 1155 doi: 10.1002/jmv.23608
|
10 |
Jie Xu, Biao Wu, Jing-Hui Wang, Ling Huang, Deng-yu Wang, Ling Zhao, Guo-ping Zhao, Ying Wang, Dimitrios Paraskevis. Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B. PLOS ONE 2015; 10(3): e0117429 doi: 10.1371/journal.pone.0117429
|
11 |
S. Mirandola, D. Campagnolo, G. Bortoletto, L. Franceschini, M. Marcolongo, A. Alberti. Large‐scale survey of naturally occurring HBV polymerase mutations associated with anti‐HBV drug resistance in untreated patients with chronic hepatitis B. Journal of Viral Hepatitis 2011; 18(7) doi: 10.1111/j.1365-2893.2011.01435.x
|
12 |
Zhihui Xu, Yan Liu, Teng Xu, Li Chen, Lanlan Si, Yao Wang, Xiaoqiang Ren, Yanwei Zhong, Jingmin Zhao, Dongping Xu. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. Journal of Clinical Virology 2010; 48(4): 270 doi: 10.1016/j.jcv.2010.05.010
|
13 |
Qi Zhang, Yun Liao, Bei Cai, Yi Li, Lixin Li, Junlong Zhang, Yunfei An, Lanlan Wang. Incidence of natural resistance mutations in naïve chronic hepatitis B patients: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2015; 30(2): 252 doi: 10.1111/jgh.12831
|
14 |
Xizhan Xu, Kuanhui Xiang, Mingze Su, Yao Li, Wei Ji, Yutang Li, Hui Zhuang, Tong Li. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses 2017; 9(8): 199 doi: 10.3390/v9080199
|
15 |
Samad Amini-Bavil-Olyaee, Sayed Younes Hosseini, Farzaneh Sabahi, Seyed-Moayed Alavian. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. International Journal of Infectious Diseases 2008; 12(1): 83 doi: 10.1016/j.ijid.2007.05.001
|
16 |
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
|
17 |
A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon. Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea. Annals of Laboratory Medicine 2014; 34(3): 230 doi: 10.3343/alm.2014.34.3.230
|
18 |
W. F. LEEMANS, M. J. TER BORG, R. A. DE MAN. Review article: success and failure of nucleoside and nucleotide analogues in chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2007; 26(s2): 171 doi: 10.1111/j.1365-2036.2007.03481.x
|
19 |
Ying Ma, Yujun Yuan, Xianglin Ma, Boru Tang, Ximei Hu, Juan Feng, Li Tian, Yaohua Ji, Xiaoguang Dou. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. Experimental and Therapeutic Medicine 2016; 12(2): 847 doi: 10.3892/etm.2016.3365
|
20 |
Xiao-Ling Wang, Song-Gang Xie, Ling Zhang, Wei-Xia Yang, Xing Wang, Hong-Zhi Jin. Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B. World Journal of Gastroenterology 2008; 14(1): 120-124 doi: 10.3748/wjg.14.120
|
21 |
Youwen Tan, Keqin Ding, Jing Su, Xuan Trinh, Zhihang Peng, Yuhua Gong, Li Chen, Qian Cui, Na Lei, Xin Chen, Rongbin Yu, Joerg F. Schlaak. The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis. PLoS ONE 2012; 7(3): e32789 doi: 10.1371/journal.pone.0032789
|
22 |
You-Wen Tan, Guo-Hong Ge, Wei Zhao, Jian-He Gan, Yun Zhao, Zhi-Lin Niu, Dong-Jun Zhang, Li Chen, Xue- Jun Yu, Li-Jun Yang. YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study. The Brazilian Journal of Infectious Diseases 2012; 16(3): 250 doi: 10.1016/S1413-8670(12)70319-7
|
23 |
Silvia Gaia, Alfredo Marzano, Antonella Olivero, Marilena Abate, Mario Rizzetto, Antonina Smedile. Inactive hepatitis B virus carriers: a favourable clinical condition. European Journal of Gastroenterology & Hepatology 2005; 17(12): 1435 doi: 10.1097/00042737-200512000-00029
|
24 |
Federico A. Di Lello, Ezequiel Ridruejo, Alfredo P. Martínez, Paula S. Pérez, Rodolfo H. Campos, Diego M. Flichman. Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure. Journal of Viral Hepatitis 2019; 26(5): 552 doi: 10.1111/jvh.13052
|
25 |
M. Sayan, S. Ã. Akhan, M. Meric. Naturally occurring aminoâacid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B. Journal of Viral Hepatitis 2010; 17(1): 23 doi: 10.1111/j.1365-2893.2009.01149.x
|
26 |
Mesut Akarsu, Aylin Sengonul, Ethem Tankurt, Ayca Arzu Sayiner, Omer Topalak, Hale Akpinar, Yusuf Hakan Abacioglu. YMDD motif variants in inactive hepatitis B carriers detected by Inno‐Lipa HBV DR assay. Journal of Gastroenterology and Hepatology 2006; 21(12): 1783 doi: 10.1111/j.1440-1746.2006.04567.x
|
27 |
Jinxin Zheng, Zheng Zeng, Duyi Zhang, Yanyan Yu, Fang Wang, Calvin Q. Pan. Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients. Liver International 2012; 32(10): 1535 doi: 10.1111/j.1478-3231.2012.02859.x
|